Syncom Formulations India LtdPharmaceuticalsINE312C01025Consolidated₹20.02+1.22 (+6.49%)Jun-26
Valuation
Market Cap₹1.88K Cr
TTM PE21.30x
Forward PE19.76x
PEG3.79
Book Value₹4.41
P/B4.53x
TTM EPS₹0.94
Fwd EPS₹1.01
TTM Revenue₹497.80 Cr
TTM PAT₹85.53 Cr
TTM EBITDA₹87.84 Cr
TTM EBIT₹81.11 Cr
Last Qtr PAT₹24.85 Cr
Last Qtr EBITDA₹26.21 Cr
Last Qtr EBIT₹24.67 Cr
Profitability
ROE20.61%
ROCE27.43%
TTM NPM17.18%
TTM EBITDA %17.65%
Curr OPM18.63%
Last OPM16.78%
Curr NPM—
Last NPM—
Curr EPS₹0.26
Last EPS₹0.27
Balance sheet
Equity₹94.00 Cr
Reserve₹320.99 Cr
Total Debt₹1.47 Cr
D/E0.00x
Interest %0.97%
Curr Interest₹0.24 Cr
Price / range
Close₹20.02
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+6.49%
1W+2.61%
1M+28.58%
3M+43.10%
6M+67.53%
1Y+10.79%
2Y-13.67%
3Y+133.33%
5Y+229.82%
Diwali+41.89%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits